Carvedilol for Treatment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

J Am Heart Assoc. 2021 Jul 20;10(14):e021518. doi: 10.1161/JAHA.121.021518. Epub 2021 Jul 14.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Carvedilol / therapeutic use*
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects
  • Pulmonary Arterial Hypertension / complications*
  • Pulmonary Arterial Hypertension / drug therapy
  • Pulmonary Arterial Hypertension / physiopathology
  • Pulmonary Wedge Pressure / drug effects
  • Stroke Volume / drug effects
  • Stroke Volume / physiology*
  • Ventricular Dysfunction, Right / drug therapy*
  • Ventricular Dysfunction, Right / etiology
  • Ventricular Dysfunction, Right / physiopathology
  • Ventricular Function, Right / physiology*

Substances

  • Antihypertensive Agents
  • Carvedilol

Associated data

  • ClinicalTrials.gov/NCT02120339